基于“泻热破瘀法”探讨大黄牡丹汤治疗急性胰腺炎的作用机制
Exploring the Mechanism of Dahuang Mudan Decoction in Treating Acute Pancreatitis Based on the “Purging Heat and Breaking Stasis Method”
DOI: 10.12677/acm.2026.1652116, PDF,    科研立项经费支持
作者: 孔祥定, 贺紫薇:黑龙江中医药大学附属第一医院外二科,黑龙江 哈尔滨;张佳莹:黑龙江护理高等专科学校,黑龙江 哈尔滨;刘 畅, 王立伟*:黑龙江中医药大学研究生院,黑龙江 哈尔滨
关键词: 急性胰腺炎泻热破瘀法大黄牡丹汤中医理论创新Acute Pancreatitis Purging Heat and Breaking Stasis Method Dahuang Mudan Decoction Innovation in Traditional Chinese Medicine Theory
摘要: 急性胰腺炎(Acute pancreatitis, AP)是一种常见的急腹症,尽管西医已形成较为成熟的治疗方案,但对AP复杂病理链的干预效果仍有限,尤其在重症急性胰腺炎(Severe Acute Pancreatitis, SAP)中,病死率仍较高。本文基于中医“泻热破瘀法”理论,提出了“AP热瘀腑实三阶段演进假说”,将AP分为“热邪炽盛期”“瘀热互结期”和“腑实瘀毒期”三个阶段,通过构建“组分–阶段–病机”的精准对应模型,探讨了经典方剂大黄牡丹汤在AP不同病程阶段的治疗机制。研究表明,大黄牡丹汤的核心活性成分通过多靶点协同作用,分别在不同阶段通过清热、破瘀、通腑等机制,抑制炎症反应,改善胰腺微环境,修复肠道屏障,降低脓毒症风险。该研究为AP的中医精准辨证治疗提供了新的理论框架,也为中西医结合治疗AP及其他复杂疾病提供了创新性思路。
Abstract: Acute pancreatitis (AP) is a common acute abdominal condition. Although Western medicine has established relatively mature treatment protocols, its intervention effects on the complex pathological cascade of AP remain limited, especially in severe acute pancreatitis (SAP), where the mortality rate remains high. Based on the traditional Chinese medicine (TCM) theory of “purging heat and breaking stasis method”, this paper proposes the “three-stage evolution hypothesis of heat, stasis, and fu-organ constipation in AP”, dividing AP into three stages: the “stage of intense heat pathogen”, the “stage of intermingled heat and stasis”, and the “stage of fu-organ constipation with stasis-toxin”. By constructing a precise “component-stage-pathogenesis” matching model, the study explores the therapeutic mechanisms of the classic formula Dahuang Mudan Decoction at different stages of AP. The results indicate that the core active components of Dahuang Mudan Decoction exert multi-target synergistic effects, including clearing heat, breaking stasis, and relieving constipation at different stages, thereby inhibiting inflammatory responses, improving the pancreatic microenvironment, repairing the intestinal barrier, and reducing the risk of sepsis. This study provides a new theoretical framework for precise TCM syndrome-based treatment of AP and offers innovative ideas for integrating TCM and Western medicine in the treatment of AP and other complex diseases.
文章引用:孔祥定, 贺紫薇, 张佳莹, 刘畅, 王立伟. 基于“泻热破瘀法”探讨大黄牡丹汤治疗急性胰腺炎的作用机制[J]. 临床医学进展, 2026, 16(5): 3017-3025. https://doi.org/10.12677/acm.2026.1652116

参考文献

[1] Guo, Y., Cao, F., Li, C., Yang, H., Xia, S. and Li, F. (2020) Continuous Hemofiltration Reduces Mortality in Severe Acute Pancreatitis: A Meta-Analysis. Emergency Medicine International, 2020, Article ID: 6474308. [Google Scholar] [CrossRef] [PubMed]
[2] Li, F., Wang, Z., Cao, Y., Pei, B., Luo, X., Liu, J., et al. (2024) Intestinal Mucosal Immune Barrier: A Powerful Firewall against Severe Acute Pancreatitis-Associated Acute Lung Injury via the Gut-Lung Axis. Journal of Inflammation Research, 17, 2173-2193. [Google Scholar] [CrossRef] [PubMed]
[3] 中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021) [J]. 浙江实用医学, 2021, 26(6): 511-519, 535.
[4] 李慧臻, 周正华, 程红杰, 等. 急性胰腺炎中医诊疗专家共识(2023) [J]. 中华中医药杂志, 2024, 39(7): 3549-3557.
[5] 周健, 高淳, 唐学典. 大黄牡丹汤加减治疗急性胰腺炎对机体炎症和应激反应的影响[J]. 中医药信息, 2017, 34(1): 62-66.
[6] Yu, T., Hou, D., Zhao, J., Lu, X., Greentree, W.K., Zhao, Q., et al. (2024) NLRP3 Cys126 Palmitoylation by ZDHHC7 Promotes Inflammasome Activation. Cell Reports, 43, Article ID: 114070. [Google Scholar] [CrossRef] [PubMed]
[7] Fu, Q., Zhai, Z., Wang, Y., Xu, L., Jia, P., Xia, P., et al. (2018) NLRP3 Deficiency Alleviates Severe Acute Pancreatitis and Pancreatitis-Associated Lung Injury in a Mouse Model. BioMed Research International, 2018, Article ID: 1294951. [Google Scholar] [CrossRef] [PubMed]
[8] Gong, J., Xiong, Z., Yu, W. and Song, Z. (2024) Bone Marrow Mesenchymal Stem Cells Alleviate Acute Severe Pancreatitis and Promote Lung Repair via Inhibiting NLRP3 Inflammasome in Rat. Digestive Diseases and Sciences, 69, 135-147. [Google Scholar] [CrossRef] [PubMed]
[9] Ge, N., Xia, Q., Yang, Z., Ding, Q. and Zeng, Z. (2015) Vascular Endothelial Injury and Apoptosis in Rats with Severe Acute Pancreatitis. Gastroenterology Research and Practice, 2015, Article ID: 235017. [Google Scholar] [CrossRef] [PubMed]
[10] Zhang, Y., Feng, Y., Zhou, S., Gao, S., Xiong, B., Gao, X., et al. (2024) Establishment of a Model of LPS-Induced Inflammatory Injury in Human Aortic Endothelial Cells. Biomedicine & Pharmacotherapy, 174, Article ID: 116576. [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, X., Wan, Y., Feng, J., Li, M. and Jiang, Z. (2021) Involvement of TLR2/4-MyD88-NF-κB Signaling Pathway in the Pathogenesis of Intracranial Aneurysm. Molecular Medicine Reports, 23, Article No. 230. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, X., Wang, H., Yang, X., Lin, Z., Shi, N., Chen, C., et al. (2021) Alleviation of Acute Pancreatitis-Associated Lung Injury by Inhibiting the P38 Mitogen-Activated Protein Kinase Pathway in Pulmonary Microvascular Endothelial Cells. World Journal of Gastroenterology, 27, 2141-2159. [Google Scholar] [CrossRef] [PubMed]
[13] 李金强, 惠亮亮. 急性胰腺炎患者肠道菌群的研究进展[J]. 中国微生态学杂志, 2024, 36(12): 1480-1484.
[14] 陆一凡, 陈宋海, 王清清, 等. 重症急性胰腺炎患者肠黏膜屏障损伤与血清二胺氧化酶和TLR9水平及肠道菌群和其代谢产物的相关性[J]. 中国微生态学杂志, 2024, 36(3): 292-297.
[15] Ma, N., Ma, D., Liu, X., Zhao, L., Ma, L., Ma, D., et al. (2023) Bisphenol P Exposure in C57BL/6 Mice Caused Gut Microbiota Dysbiosis and Induced Intestinal Barrier Disruption via LPS/TLR4/NF-κB Signaling Pathway. Environment International, 175, Article ID: 107949. [Google Scholar] [CrossRef] [PubMed]
[16] Fan, J., Wu, Y., Wang, X., Ullah, H., Ling, Z., Liu, P., et al. (2026) The Probiotic Enhances Donor Microbiota Stability and Improves the Efficacy of Fecal Microbiota Transplantation for Treating Colitis. Journal of Advanced Research, 79, 209-221. [Google Scholar] [CrossRef] [PubMed]
[17] Prochazkova, P., Roubalova, R., Dvorak, J., Tlaskalova-Hogenova, H., Cermakova, M., Tomasova, P., et al. (2019) Microbiota, Microbial Metabolites, and Barrier Function in a Patient with Anorexia Nervosa after Fecal Microbiota Transplantation. Microorganisms, 7, Article 338. [Google Scholar] [CrossRef] [PubMed]
[18] 陈何红, 张永涛, 王停. “脾瘅”证治探微[J]. 河南中医, 2001(2): 9-10.
[19] 行人. 制怒五诀[J]. 农家之友, 2001(3): 43.
[20] 《黄帝内经》中土理论思想初探[J]. 河南中医, 2016, 36(10): 1686-1688.
[21] 甘盼盼, 刘畅, 王佳春, 等. 基于肺痈“热毒血凝”理论从风、热、毒、瘀、虚论治支气管扩张并感染[J]. 西部中医药, 2022, 35(1): 60-62.
[22] 张泽涵, 张翼飞, 叶冠成, 等. 《辨舌指南》“舌形态”理论特色探析[J]. 中华中医药杂志, 2023, 38(2): 730-734.
[23] 梅国强. 论叶天士“益胃阴”之运用规律[J]. 江西中医药, 1983(3): 1-4.
[24] 张志豪. 谈谈《伤寒论》的和法[J]. 中医杂志, 1983(2): 56-57.
[25] 刘桂元, 罗利亚, 李晓, 等. 大黄蒽醌类化合物抗炎作用研究进展[J]. 中成药, 2023, 45(11): 3693-3701.
[26] Casali, E., Serapian, S.A., Gianquinto, E., Castelli, M., Bertinaria, M., Spyrakis, F., et al. (2023) NLRP3 Monomer Functional Dynamics: From the Effects of Allosteric Binding to Implications for Drug Design. International Journal of Biological Macromolecules, 246, Article ID: 125609. [Google Scholar] [CrossRef] [PubMed]
[27] 杨丹. 大黄牡丹汤对急性胰腺炎肺损伤大鼠的干预作用及分子机制研究[D]: [硕士学位论文]. 兰州: 甘肃中医药大学, 2022.
[28] Liao, H., Banbury, L.K. and Leach, D.N. (2006) Elucidation of Danzhixiaoyao Wan and Its Constituent Herbs on Antioxidant Activity and Inhibition of Nitric Oxide Production. Evidence-Based Complementary and Alternative Medicine, 4, 425-430. [Google Scholar] [CrossRef] [PubMed]
[29] 刘玲玲, 张鲁宁, 姜胜男, 等. 基于Keap1/Nrf2/ARE信号通路探讨丹皮酚改善酒精性肝、脑损伤小鼠氧化应激损伤与炎症的作用机制[J]. 安徽中医药大学学报, 2024, 43(2): 73-80.
[30] 张鹏, 李俞甫, 吴尚泽, 等. 丹皮酚对L-精氨酸诱导的小鼠急性胰腺炎氧化损伤的影响[J]. 畜牧兽医学报, 2021, 52(7): 1983-1990.
[31] 曾信豪, 谢东可, 郑皓, 等. 苦杏仁苷对新生大鼠坏死性小肠结肠炎的保护作用[J]. 中国比较医学杂志, 2022, 32(1): 75-81.
[32] 徐立宇. 苦杏仁对老年慢传输型便秘大鼠结肠Cajal间质细胞的影响[C]//浙江省医学会老年医学分会. 2018年浙江省老年医学学术年会论文汇编. 杭州: 浙江医院老年病综合示范病房, 2018: 92-93.
[33] Xu, D., Xie, Y., Cheng, J., He, D., Liu, J., Fu, S., et al. (2024) Amygdalin Alleviates DSS-Induced Colitis by Restricting Cell Death and Inflammatory Response, Maintaining the Intestinal Barrier, and Modulating Intestinal Flora. Cells, 13, Article 444. [Google Scholar] [CrossRef] [PubMed]